Latest Breaking News On - Nurexone biologic chart - Page 1 : vimarsana.com

19.04.2024 - TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) - NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Lior Shaltiel, CEO and Director . Seite 1

City ofUnited kingdomExosomes europeEva reuterLior shaltielNurexone biologic incThesis capital incExone biologicCentral nervous systemOrphan drug designationExecutive officerNurexone biologic chartUrexone biologic kursUrexone biologic aktie